France, Germany, Italy and Netherlands sign deal for Covid-19 vaccine

The four countries, grouped together in an 'Inclusive Vaccines Alliance', struck a deal this weekend with pharma group AstraZeneca to receive a Covid-19 virus vaccine under development by researchers at Oxford university in Britain, and which it is hoped will be available at the end of the year.

Reading articles is for subscribers only. Subscribe now.

Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing capacity continue at pace, reports FRANCE 24.